Augusta, GA
97°
Sunny
6:19 am8:41 pm EDT
June 24, 2024 1:58 pm

Local News

Research in Georgia receives boost for Alzheimer’s treatments, cure

iStock

by Shanteya Hudson

Research in Georgia is getting a boost to help enhance the lives of people living with Alzheimer’s disease and provide better support.

In Georgia, more than 150,000 people age 65 and older are living with Alzheimer’s, and the number is only expected to rise.

Leslie Tripp Holland, senior director of marketing and communications for the Alzheimer’s Association, said the state has received an additional $600,000 to advance research efforts.

“For instance, we have one researcher at Emory University,” Holland explained. “Her research brings dementia awareness into the Black American churches and she is creating dementia-friendly congregations.”

Right now, 19 projects are active in such areas as Atlanta, Athens and Kennesaw. Holland noted in addition to the search for a cure, many of the projects are assisting in risk mitigation, creating opportunities to spread awareness and allowing people to participate in clinical trials, ultimately helping provide increased representation in research.

Breaking down the stigmas surrounding brain health, dementia, and Alzheimer’s is another significant aspect of the research being conducted in Georgia. Holland emphasized by investing in research, the state is advancing its understanding of the diseases while working toward developing effective treatments.

“We now have two FDA-approved treatments that are also approved by Medicare that clinically changed the course of the disease,” Holland stressed. “We have never had that in the past.”

The funding was part of a $100 million investment into research around the country by the Alzheimer’s Association, the largest investment since 1980. Data show more than 6 million people in the U.S. are living with Alzheimer’s, and by 2050, this number is projected to rise to nearly 13 million.

This article originally appeared on Public News Service and is republished here under a Creative Commons license.